CLL patients with BCR stereotypy showed distinct clinical profiles; for example, the subset #2 subgroup exhibited aggressive behavior independent of the mutational status of the clonotypic IGHV gene, while the IGHV4-34-containing subsets #4 and #16 had a more indolent progression. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.